MW3476A1 - Pharmacologically active compounds - Google Patents
Pharmacologically active compoundsInfo
- Publication number
- MW3476A1 MW3476A1 MW34/76A MW3476A MW3476A1 MW 3476 A1 MW3476 A1 MW 3476A1 MW 34/76 A MW34/76 A MW 34/76A MW 3476 A MW3476 A MW 3476A MW 3476 A1 MW3476 A1 MW 3476A1
- Authority
- MW
- MALAWI
- Prior art keywords
- active compounds
- pharmacologically active
- pharmacologically
- compounds
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4034175 | 1975-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
MW3476A1 true MW3476A1 (en) | 1977-11-09 |
Family
ID=10414412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MW34/76A MW3476A1 (en) | 1975-10-02 | 1976-09-10 | Pharmacologically active compounds |
Country Status (36)
Country | Link |
---|---|
JP (2) | JPS5246087A (fr) |
AR (1) | AR221682A1 (fr) |
AT (1) | AT358045B (fr) |
AU (1) | AU504897B2 (fr) |
BE (1) | BE846452A (fr) |
BG (1) | BG25224A3 (fr) |
CA (1) | CA1067076A (fr) |
CH (1) | CH625801A5 (fr) |
CS (1) | CS203003B2 (fr) |
DD (1) | DD126563A5 (fr) |
DE (1) | DE2643670C2 (fr) |
DK (1) | DK442476A (fr) |
ES (1) | ES452060A1 (fr) |
FI (1) | FI61701C (fr) |
FR (1) | FR2326192A1 (fr) |
GR (1) | GR61307B (fr) |
HU (1) | HU175537B (fr) |
IE (1) | IE44845B1 (fr) |
IL (1) | IL50503A (fr) |
IN (1) | IN146736B (fr) |
IT (2) | IT1070839B (fr) |
LU (1) | LU75922A1 (fr) |
MW (1) | MW3476A1 (fr) |
MX (1) | MX4614E (fr) |
NL (1) | NL7609917A (fr) |
NO (1) | NO145792C (fr) |
NZ (1) | NZ181959A (fr) |
OA (1) | OA05445A (fr) |
PH (1) | PH13921A (fr) |
PL (1) | PL105828B1 (fr) |
PT (1) | PT65590B (fr) |
RO (1) | RO73511A (fr) |
SE (1) | SE431872B (fr) |
YU (1) | YU237276A (fr) |
ZA (1) | ZA765498B (fr) |
ZM (1) | ZM12176A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MW5076A1 (en) * | 1975-12-29 | 1978-02-08 | Smith Kline French Lab | Pharmacologicalle active compounds |
NZ186511A (en) | 1977-03-19 | 1980-11-14 | Smith Kline French Lab | 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones |
ZA782129B (en) | 1977-04-20 | 1979-03-28 | Ici Ltd | Hertocyclic derivatives |
US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
JPS54104816A (en) * | 1978-01-27 | 1979-08-17 | Memorex Corp | Magnetic recorder tape reel |
IN151188B (fr) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
PH16240A (en) * | 1978-04-11 | 1983-08-11 | Smith Kline French Lab | Process for making histamine antagonist |
IL57416A (en) * | 1978-05-30 | 1983-03-31 | Smith Kline French Lab | Nitro compounds,processes for preparing them and compositions containing them |
ZA793443B (en) * | 1978-07-26 | 1980-12-31 | Glaxo Group Ltd | Heterocyclic derivatives |
US4374836A (en) | 1978-10-16 | 1983-02-22 | Imperial Chemical Industries Ltd. | Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them |
US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
JPS55145683A (en) * | 1979-04-26 | 1980-11-13 | Smith Kline French Lab | Pyrimidone derivative |
CA1155842A (fr) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Composes |
ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
PT75074B (en) * | 1981-06-27 | 1986-02-26 | Smith Kline French Lab | Process for preparing certain pyrimidone derivatives and compositions containing them |
NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
JPS5993074A (ja) * | 1982-10-01 | 1984-05-29 | スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド | ピリミドン誘導体 |
DE8309239U1 (de) * | 1983-03-29 | 1983-09-29 | Basf Ag, 6700 Ludwigshafen | Bandspule, insbesondere fuer magnetbaender |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1397436A (en) * | 1972-09-05 | 1975-06-11 | Smith Kline French Lab | Heterocyclic n-cyanoguinidines |
GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
-
1976
- 1976-09-06 IN IN1633/CAL/76A patent/IN146736B/en unknown
- 1976-09-07 NZ NZ181959A patent/NZ181959A/xx unknown
- 1976-09-07 NL NL7609917A patent/NL7609917A/xx unknown
- 1976-09-10 MW MW34/76A patent/MW3476A1/xx unknown
- 1976-09-14 PT PT65590A patent/PT65590B/pt unknown
- 1976-09-14 IT IT27192/76A patent/IT1070839B/it active
- 1976-09-14 ZA ZA765498A patent/ZA765498B/xx unknown
- 1976-09-16 IL IL50503A patent/IL50503A/xx unknown
- 1976-09-20 SE SE7610409A patent/SE431872B/xx not_active IP Right Cessation
- 1976-09-22 BE BE170830A patent/BE846452A/fr not_active IP Right Cessation
- 1976-09-24 FR FR7628824A patent/FR2326192A1/fr active Granted
- 1976-09-24 AT AT711976A patent/AT358045B/de not_active IP Right Cessation
- 1976-09-24 PH PH18943A patent/PH13921A/en unknown
- 1976-09-27 CS CS766222A patent/CS203003B2/cs unknown
- 1976-09-28 YU YU02372/76A patent/YU237276A/xx unknown
- 1976-09-28 GR GR51794A patent/GR61307B/el unknown
- 1976-09-28 DE DE2643670A patent/DE2643670C2/de not_active Expired
- 1976-09-28 CA CA262,162A patent/CA1067076A/fr not_active Expired
- 1976-09-29 IE IE2154/76A patent/IE44845B1/en unknown
- 1976-09-29 OA OA55946A patent/OA05445A/fr unknown
- 1976-09-30 AR AR264926A patent/AR221682A1/es active
- 1976-09-30 DD DD195067A patent/DD126563A5/xx unknown
- 1976-09-30 AU AU18295/76A patent/AU504897B2/en not_active Expired
- 1976-10-01 DK DK442476A patent/DK442476A/da not_active Application Discontinuation
- 1976-10-01 CH CH1248276A patent/CH625801A5/de not_active IP Right Cessation
- 1976-10-01 JP JP51118904A patent/JPS5246087A/ja active Granted
- 1976-10-01 NO NO763371A patent/NO145792C/no unknown
- 1976-10-01 MX MX764951U patent/MX4614E/es unknown
- 1976-10-01 HU HU76SI1543A patent/HU175537B/hu unknown
- 1976-10-01 FI FI762803A patent/FI61701C/fi not_active IP Right Cessation
- 1976-10-01 BG BG7600034338A patent/BG25224A3/xx unknown
- 1976-10-01 PL PL1976192809A patent/PL105828B1/pl unknown
- 1976-10-01 ZM ZM121/76A patent/ZM12176A1/xx unknown
- 1976-10-01 ES ES452060A patent/ES452060A1/es not_active Expired
- 1976-10-01 LU LU75922A patent/LU75922A1/xx unknown
- 1976-10-02 RO RO7687887A patent/RO73511A/fr unknown
-
1978
- 1978-12-11 IT IT7830708A patent/IT7830708A0/it unknown
-
1980
- 1980-12-09 JP JP55174447A patent/JPS609755B2/ja not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA763652B (en) | Pharmacologically active compounds | |
PT65590B (en) | Pharmacologically active compounds | |
ZM14376A1 (en) | Pharmacologically active compounds | |
PT67046B (en) | Pharmacologically active compounds | |
ZA764082B (en) | Pharmacologically active compounds | |
ZA7682B (en) | Pharmacologically active compounds | |
ZA765331B (en) | Novel pharmaceutically active compounds | |
PT65377B (en) | Pharmacologically active compounds | |
ZA771018B (en) | Pharmacologically active compounds | |
ZA761324B (en) | Pharmaceutically active compounds | |
ZM9776A1 (en) | Pharmacologically active compounds | |
PT65839A (en) | Pharmacologically active compounds | |
ZA762536B (en) | Pharmacologically active compounds | |
AU2730377A (en) | Pharmacologically active compounds | |
ZA774221B (en) | Pharmacologically active compounds | |
ZA774552B (en) | Pharmacologically active compounds | |
ZA774500B (en) | Pharmacologically active compounds | |
ZA77508B (en) | Pharmacologically active compounds | |
ZA766201B (en) | Pharmacologically active compounds | |
AU1059176A (en) | Pharmacologically active compositions | |
ZA775268B (en) | Pharmacologically active compounds | |
MW2876A1 (en) | Pharmacologically active compounds | |
MW2776A1 (en) | Pharmacologically active compounds | |
MW2676A1 (en) | Pharmacologically active compounds |